Envista Holdings Corporation

Equities

NVST

US29415F1049

Medical Equipment, Supplies & Distribution

Market Closed - Nyse Other stock markets 04:00:02 2024-05-20 pm EDT			5-day change	1st Jan Change
18.27 ^USD	-1.40%		-3.13%	-24.06%

May. 01	Earnings Flash (NVST) ENVISTA HOLDINGS CORPORATION Reports Q1 EPS $0.26, vs. Street Est of $0.32	MT
May. 01	Earnings Flash (NVST) ENVISTA HOLDINGS CORPORATION Posts Q1 Revenue $623.6M, vs. Street Est of $634.5M	MT

Envista Holdings Corporation Announces Termination of Jean-Claude Kyrillos as SVP and President, Diagnostics and Digital Solutions, Effective June 30, 2023

April 14, 2023 at 04:15 pm EDT

On April 11, 2023, Envista Holdings Corporation (the “Company”) and Jean-Claude Kyrillos, the Company's SVP and President, Diagnostics and Digital Solutions, mutually agreed that Mr. Kyrillos' employment will terminate effective June 30, 2023.

Latest news about Envista Holdings Corporation

Earnings Flash (NVST) ENVISTA HOLDINGS CORPORATION Reports Q1 EPS $0.26, vs. Street Est of $0.32	May. 01	MT
Earnings Flash (NVST) ENVISTA HOLDINGS CORPORATION Posts Q1 Revenue $623.6M, vs. Street Est of $634.5M	May. 01	MT
Transcript : Envista Holdings Corporation, Q1 2024 Earnings Call, May 01, 2024	May. 01
Envista Holdings Corporation Reports Earnings Results for the First Quarter Ended March 29, 2024	May. 01	CI
North American Morning Briefing : Investors Brace -2-	Apr. 29	DJ
Morgan Stanley Downgrades Envista Holdings to Equalweight From Overweight, Cuts Price Target to $21 From $33	Apr. 26	MT
Envista Holdings Names Paul Keel as CEO	Apr. 15	MT
Envista Holdings Corporation Announces Chief Executive Officer Changes	Apr. 15	CI
Envista Holdings Corporation Announces Management Changes	Apr. 15	CI
Bausch + Lomb to Present New Data and Analyses at American Society of Cataract and Refractive Surgery Annual Meeting	Mar. 27	MT
Envista Holdings Starts CEO Succession Process	Feb. 26	MT
Leerink Partners Initiates Envista Holdings at Underperform Rating With $19 Price Target	Feb. 26	MT
North American Morning Briefing : Stock Futures -2-	Feb. 12	DJ
UBS Adjusts Envista Holdings Price Target to $23 From $26, Maintains Neutral Rating	Feb. 09	MT
Jefferies Downgrades Envista Holdings to Hold From Buy, Adjusts Price Target to $23 From $30	Feb. 09	MT
North American Morning Briefing : Stock Futures -2-	Feb. 09	DJ
William Blair Downgrades Envista Holdings to Market Perform From Outperform	Feb. 08	MT
Sector Update: Health Care Stocks Steady Premarket Thursday	Feb. 08	MT
Envista Holdings' Q4 Adjusted Earnings Fall, Revenue Rises; Shares Fall Pre-Bell	Feb. 08	MT
Transcript : Envista Holdings Corporation, Q4 2023 Earnings Call, Feb 07, 2024	Feb. 07
Earnings Flash (NVST) ENVISTA HOLDINGS CORPORATION Posts Q4 Revenue $645.6M, vs. Street Est of $638.4M	Feb. 07	MT
Earnings Flash (NVST) ENVISTA HOLDINGS CORPORATION Posts Q4 EPS $0.29, vs. Street Est of $0.34	Feb. 07	MT
Envista Holdings Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 07	CI
Envista Holdings Corporation Provides Earnings Guidance for the Full Year 2024	Feb. 07	CI
Envista Holdings Corporation Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Feb. 07	CI

Chart Envista Holdings Corporation

Duration

Period

More charts

Company Profile

Envista Holdings Corporation is a dental products company. The Company provides dental consumables, solutions, technology, and services. It has approximately 30 dental brands, including Nobel Biocare, Ormco and Kerr united. The Company operates through two segments: Specialty Products & Technologies and Equipment & Consumables. The Specialty Products & Technologies segment develops, manufactures, and markets dental implant systems, including regenerative solutions, dental prosthetics and associated treatment software and technologies, as well as orthodontic bracket systems, aligners, and lab products. The Equipment & Consumables segment develops, manufactures, and markets dental equipment and supplies used in dental offices, including digital imaging systems, software, and other visualization/magnification systems, and endodontic systems and related products; restorative materials, rotary burs, impression materials, bonding agents and cements, and infection prevention products.

Sector

Medical Equipment, Supplies & Distribution

Calendar

10:30am - Annual General Meeting

More about the company

Income Statement Evolution

More financial data

Ratings for Envista Holdings Corporation

Trading Rating

Investor Rating

ESG Refinitiv

B-

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

18.27 USD

Average target price

20.5 USD

Spread / Average Target

+12.21%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.
ENVISTA HOLDINGS CORPORATION	-24.06%	3.14B
ABBOTT LABORATORIES	-6.23%	180B
MEDTRONIC PLC	+2.59%	112B
BECTON, DICKINSON AND COMPANY	-2.75%	68.53B
DEXCOM, INC.	+5.32%	51.97B
CENCORA, INC.	+7.61%	44.08B
HOYA CORPORATION	+5.62%	42.23B
METTLER-TOLEDO INTERNATIONAL, INC.	+25.17%	32.43B
TERUMO CORPORATION	+16.72%	26.39B
WEST PHARMACEUTICAL SERVICES, INC.	-2.66%	24.97B

Other Medical Equipment, Supplies & Distribution